Skip to contentPERCEPTIVE LIFE SCIENCES MASTER FUND LTD — ZONAGEN INC insider: 339 transactions · InsiderLensPERCEPTIVE LIFE SCIENCES MASTER FUND LTD
- 10% owner at SOLENO THERAPEUTICS INC · on record since May 26, 2023
- Director at Nautilus Biotechnology, Inc. · on record since Jun 20, 2023
- 10% owner at INDEVUS PHARMACEUTICALS INC · on record since Jun 29, 2006
- Former 10% Owner at CARGO Therapeutics, Inc. · on record since Nov 14, 2023
- 10% owner at Orchestra BioMed Holdings, Inc. · on record since Jul 17, 2024
- 10% owner at Adagio Medical Holdings, Inc. · on record since Aug 1, 2024
- 10% owner at Rain Enhancement Technologies Holdco, Inc. · on record since Apr 27, 2021
- 10% owner at BIOENVISION INC · on record since Aug 22, 2007
- Director at Adagio Medical Holdings, Inc. · on record since Feb 14, 2025
- 10% owner at XTL BIOPHARMACEUTICALS LTD · on record since Dec 31, 2007
- 10% owner at MACROCHEM CORP · on record since Dec 28, 2007
- 10% owner at OPTIMER PHARMACEUTICALS INC · on record since Dec 27, 2007
- 10% owner at PENWEST PHARMACEUTICALS CO · on record since Jan 31, 2008
- Director at Immatics N.V. · on record since Mar 18, 2026
- Director at Kardigan, Inc. · on record since Jun 18, 2026
- Director at ARYA SCIENCES ACQUISITION CORP. · on record since May 24, 2021
- (See Footnote 1) at CYPRESS BIOSCIENCE INC · on record since Aug 8, 2003
- 10% owner at BIOSANTE PHARMACEUTICALS INC · on record since Aug 13, 2003
- Managing Member at BIOSANTE PHARMACEUTICALS INC · on record since Aug 13, 2003
- 10% owner at MIRAVANT MEDICAL TECHNOLOGIES · on record since Jun 8, 2004
- 10% owner at ZONAGEN INC · on record since Feb 28, 2011
- 10% owner at TRIMERIS INC · on record since Jul 29, 2011
- 10% owner at AP PHARMA INC /DE/ · on record since Jul 7, 2011
- Director at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at MeiraGTx Holdings plc · on record since Apr 23, 2026
- 10% owner at ACELRX PHARMACEUTICALS INC · on record since Dec 13, 2012
- 10% owner at Aegerion Pharmaceuticals, Inc. · on record since Dec 5, 2012
- 10% owner at ANTARES PHARMA INC · on record since Feb 12, 2004
- 10% owner at AMICUS THERAPEUTICS INC · on record since May 30, 2014
- Director at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at Solid Biosciences Inc. · on record since Jun 11, 2026
- 10% owner at PAULSON CAPITAL CORP · on record since Aug 4, 2014
- 10% owner at Aldeyra Therapeutics, Inc. · on record since Oct 28, 2015
- Former Director at Nautilus Biotechnology, Inc. · on record since Jun 11, 2021
- 10% owner at Versartis, Inc. · on record since Sep 28, 2016
- No longer a 10% Owner. at AMICUS THERAPEUTICS INC · on record since Aug 26, 2016
- 10% owner at CORILLIAN CORP · on record since May 25, 2017
- 10% owner at ZOGENIX, INC. · on record since May 18, 2017
- 10% owner at Quotient Ltd · on record since Oct 26, 2017
- 10% owner at Global Blood Therapeutics, Inc. · on record since Dec 19, 2017
- 10% owner at LA JOLLA PHARMACEUTICAL CO · on record since Dec 18, 2017
- 10% owner at R&R ACQUISITION VI, INC · on record since Nov 15, 2017
- 10% owner at Biodel Inc · on record since Dec 4, 2017
- 10% owner at AGILE THERAPEUTICS INC · on record since Mar 28, 2018
- 10% owner at Motus GI Holdings, Inc. · on record since Feb 21, 2018
- 10% owner at Kadmon Holdings, LLC · on record since Jun 22, 2018
- 10% owner at Dova Pharmaceuticals, Inc. · on record since Jun 13, 2018
- Director at Crinetics Pharmaceuticals, Inc. · on record since Aug 27, 2018
- 10% owner at Crinetics Pharmaceuticals, Inc. · on record since Aug 27, 2018
- Former 10% Owner at AGILE THERAPEUTICS INC · on record since Jul 26, 2018
- Former 10% Owner at Global Blood Therapeutics, Inc. · on record since Jul 25, 2018
- 10% owner at Verrica Pharmaceuticals Inc. · on record since Aug 1, 2018
- 10% owner at Athenex, Inc. · on record since Jun 20, 2019
- 10% owner at Foamix Pharmaceuticals Ltd. · on record since Aug 6, 2019
- 10% owner at Lyra Therapeutics, Inc. · on record since Apr 30, 2020
- 10% owner at LEAP THERAPEUTICS, INC. · on record since Jun 24, 2020
- 10% owner at VYNE Therapeutics Inc. · on record since Jun 11, 2020
- 10% owner at LeonaBio, Inc. · on record since Sep 22, 2020
- Director at Ceres, Inc. · on record since Oct 29, 2020
- Director at ARYA Sciences Acquisition Corp II · on record since Oct 22, 2020
- Director at LeonaBio, Inc. · on record since Jan 27, 2021
- 10% owner at SCYNEXIS INC · on record since Jan 26, 2021
- 10% owner at Ignyta, Inc. · on record since Mar 16, 2021
- Director at Landos Biopharma, Inc. · on record since Feb 9, 2021
- 10% owner at Landos Biopharma, Inc. · on record since Feb 9, 2021
- Director at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- 10% owner at CATABASIS PHARMACEUTICALS INC · on record since Feb 3, 2021
- 10% owner at LianBio · on record since Oct 29, 2021
- 10% owner at ISCO INTERNATIONAL INC · on record since Oct 14, 2021
- 10% owner at Nautilus Biotechnology, Inc. · on record since Dec 10, 2021
- Director at LianBio · on record since Nov 5, 2021
- 10% owner at Acrivon Therapeutics, Inc. · on record since Nov 18, 2022
Insider trading activity of PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
- Transactions on record
- 339
- since Dec 27, 2007
- Open-market buys
- 183
- $555M
- Open-market sells
- 45
- $82.1M
- Companies traded
- 41
- last filing Mar 11, 2026
Figures computed from official regulatory filings — methodology.
Companies where PERCEPTIVE LIFE SCIENCES MASTER FUND LTD has traded
- Solid Biosciences Inc.2 tx · $50M · Mar 11, 2026
- MeiraGTx Holdings plc7 tx · $82M · Jan 2, 2026
- Orchestra BioMed Holdings, Inc.2 tx · $6.1M · Aug 5, 2025
- Aldeyra Therapeutics, Inc.15 tx · $37.6M · Apr 7, 2025
- Acrivon Therapeutics, Inc.1 tx · $20M · Apr 15, 2024
- LianBio6 tx · $365.9K · Feb 20, 2024
- CATABASIS PHARMACEUTICALS INC7 tx · $36M · Oct 18, 2023
- Nautilus Biotechnology, Inc.5 tx · $56.1M · Jun 20, 2023
- SOLENO THERAPEUTICS INC3 tx · $188.2K · Jun 1, 2023
Track record of PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Statistical track record
Free- Open-market buys
- 202
- Last buy
- Aug 1, 2025
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
Co-insiders of PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
4 tx · $84.9M · Aug 18, 2022
Perceptive Xontogeny Venture Fund, LPCATABASIS PHARMACEUTICALS INC +3
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Mar 11, 2026 | AwardD | 8,912,655 | 5.61 USD | $50M | SEC |
| Jan 2, 2026 | Other | -2,300,000 | 7.91 USD | $18.2M | SEC |
| Aug 5, 2025 | BuyD | 1,500,000 | 2.75 USD | $4.1M | SEC |
| Aug 5, 2025 | Buy | 700,000 | 2.75 USD | $1.9M | SEC |
| Apr 7, 2025 | Sell | -3,400,000 | 1.42 USD | $4.8M | SEC |
| Apr 15, 2024 | Buy | 2,353,000 | 8.50 USD | $20M | SEC |
| Apr 3, 2024 | Buy | 8,374 | 3.25 USD | $27.2K | SEC |
| Apr 3, 2024 | Buy | 186,051 | 3.44 USD | $640K | SEC |
| Apr 3, 2024 | Buy | 309,847 | 4.09 USD | $1.3M | SEC |
| Feb 20, 2024 | ExerciseD | -36,300 | 0.00 USD | $0 | SEC |
| Feb 20, 2024 | ExerciseD | -36,300 | 0.00 USD | $0 | SEC |
| Feb 20, 2024 | Other | -19,218 | 4.76 USD | $91.5K | SEC |
| Feb 20, 2024 | Exercise | 36,300 | 2.52 USD | $91.5K | SEC |
| Feb 20, 2024 | Exercise | 36,300 | 2.52 USD | $91.5K | SEC |
| Feb 20, 2024 | Other | -19,218 | 4.76 USD | $91.5K | SEC |
| Oct 18, 2023 | BuyD | 921,093 | 6.51 USD | $6M | SEC |
| Oct 18, 2023 | Sell | -306,499 | 1.74 USD | $533.3K | SEC |
| Oct 18, 2023 | BuyD | 460,546 | 6.51 USD | $3M | SEC |
| Oct 18, 2023 | Buy | 460,546 | 6.51 USD | $3M | SEC |
| Oct 18, 2023 | Sell | -2,450,000 | 1.60 USD | $3.9M | SEC |
| Oct 18, 2023 | BuyD | 614,062 | 6.51 USD | $4M | SEC |
| Oct 18, 2023 | Buy | 614,062 | 6.51 USD | $4M | SEC |
| Oct 18, 2023 | BuyD | 921,093 | 6.51 USD | $6M | SEC |
| Jun 20, 2023 | AwardD | 45,000 | 0.00 USD | $0 | SEC |
| Jun 1, 2023 | Buy | 17,500 | 5.34 USD | $93.5K | SEC |